SecBot SecBot
Insider Cluster (4 insiders) ·Filed Sep 2, 2026

RXST

RxSight, Inc.
BEARISH
Impact 4/10
Horizondays Processed1mo ago
Insider cluster: 4 insiders, $0.1M total
Actionable Insight ▼ Bearish

Monitor for upcoming earnings or material news that could explain the selling; the non-cash equity transactions on September 5 are routine and do not provide additional signal.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
RXST ▼ -28.44% at T+20d
SHORT call ✓ call won +28.44% · α vs SPY +27.25% · entry $6.54 → $4.68
Next anchor: T+60d in 4w
Latest observation: T+35 +30.61% FF3 residual α
Entry = T+0 close
Sep 2, 2026
via day close
T+1d
-2.52%
call +2.52% · α +2.14%
$6.38
settled 8w ago
T+5d
-7.95%
call +7.95% · α +6.80%
$6.02
settled 7w ago
T+20d
-28.44%
call +28.44% · α +27.25%
$4.68
settled 27d ago
T+60d
Pending
in 4w

Price Chart

Loading chart...

Executive Summary

Four RxSight insiders, including the CFO, CMO, and COO, sold a total of $118K in open-market shares on September 2, 2026, at $6.96 per share. The non-cash equity grants and dispositions on September 5 are routine compensation events and do not alter the bearish signal from the open-market sales.

Key Financial Metrics

Direction
selling
Total Value
$118.0K
Insiders
4

Key Facts

  • Four insiders sold $118K in open-market shares on September 2, 2026.
  • Sales were at $6.96 per share, representing ~0.04% of the $268M market cap.
  • CFO Wilterding sold $54K, CMO Kurtz sold $35K, COO Goldshleger sold $14K, and Weinberg sold $14K.
  • Non-cash equity grants and dispositions on September 5 are routine compensation events.

Financial Impact

Insider sales of $118K, or ~0.04% of market cap, are modest in absolute terms but notable as a cluster involving multiple C-suite executives.

insider selling

Risk Factors

  • Insider selling cluster may indicate management's lack of confidence in near-term prospects.
  • Low market cap ($268M) and bearish analyst consensus (7% bullish) increase vulnerability to negative sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
7% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RXST-1789002065017
7 reports for RXST
Performance horizon
Filters
Rows
Reports for RXST — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 3/10
$4.97awaiting T+20—$4.90 (−1.41%)
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 3/10
$4.97awaiting T+20—$4.90 (−1.41%)
Oct 20, 2026
7d ago
Press Release
NEUTRAL ★ 2/10
$4.90awaiting T+20—$4.90 (+0.00%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$6.54 $4.68▲ +28.44%▲ +27.25%$4.90 (+25.08%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.54 $4.68▼ −28.44%▼ −27.25%$4.90 (−25.08%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$7.20 $6.16▼ −14.44%▼ −19.08%$4.90 (−31.94%)
Feb 27, 2026
34w ago
EFFECT
NEUTRAL ★ 4/10
$7.48 $6.26▼ −16.31%▼ −8.75%$4.90 (−34.49%)
Showing 7 of 7

US Market Status

Market Closed — Opens Thu (10h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026